GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease

NCT00950807 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium
DRUG: Placebo
DRUG: GSK573179

Sponsor

GlaxoSmithKline